These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 12841942
1. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats. Shimoyama Y, Hirabayashi K, Matsumoto H, Sato T, Shibata S, Inoue H. J Pharm Pharmacol; 2003 Jun; 55(6):811-7. PubMed ID: 12841942 [Abstract] [Full Text] [Related]
2. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases. Su X, Lawrence H, Ganeshapillai D, Cruttenden A, Purohit A, Reed MJ, Vicker N, Potter BV. Bioorg Med Chem; 2004 Aug 15; 12(16):4439-57. PubMed ID: 15265495 [Abstract] [Full Text] [Related]
6. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives. Su X, Vicker N, Lawrence H, Smith A, Purohit A, Reed MJ, Potter BV. J Steroid Biochem Mol Biol; 2007 May 15; 104(3-5):312-20. PubMed ID: 17493801 [Abstract] [Full Text] [Related]
7. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine. Heilmann P, Heide J, Hundertmark S, Schöneshöfer M. Exp Clin Endocrinol Diabetes; 1999 May 15; 107(6):370-8. PubMed ID: 10543414 [Abstract] [Full Text] [Related]
8. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Stanetty C, Czollner L, Koller I, Shah P, Gaware R, Cunha TD, Odermatt A, Jordis U, Kosma P, Classen-Houben D. Bioorg Med Chem; 2010 Nov 01; 18(21):7522-41. PubMed ID: 20851614 [Abstract] [Full Text] [Related]
9. A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2. Vicker N, Su X, Lawrence H, Cruttenden A, Purohit A, Reed MJ, Potter BV. Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3263-7. PubMed ID: 15149687 [Abstract] [Full Text] [Related]
10. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Gaware R, Khunt R, Czollner L, Stanetty C, Da Cunha T, Kratschmar DV, Odermatt A, Kosma P, Jordis U, Classen-Houben D. Bioorg Med Chem; 2011 Mar 15; 19(6):1866-80. PubMed ID: 21376605 [Abstract] [Full Text] [Related]
15. 11Beta-hydroxysteroid dehydrogenase bioactivity is increased in the colon but not kidneys of rats given supplementary thyroxine. Ruszymah BH, Zaiton Z, Aminuddin S, Khalid BA. Exp Clin Endocrinol Diabetes; 2001 Mar 15; 109(4):227-30. PubMed ID: 11453035 [Abstract] [Full Text] [Related]
16. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues. Stokes J, Noble J, Brett L, Phillips C, Seckl JR, O'Brien C, Andrew R. Invest Ophthalmol Vis Sci; 2000 Jun 15; 41(7):1629-38. PubMed ID: 10845579 [Abstract] [Full Text] [Related]
17. In vivo inhibition of renal 11beta-hydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption. Bailey MA, Unwin RJ, Shirley DG. Clin Sci (Lond); 2001 Aug 15; 101(2):195-8. PubMed ID: 11473496 [Abstract] [Full Text] [Related]
18. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2. Kratschmar DV, Vuorinen A, Da Cunha T, Wolber G, Classen-Houben D, Doblhoff O, Schuster D, Odermatt A. J Steroid Biochem Mol Biol; 2011 May 15; 125(1-2):129-42. PubMed ID: 21236343 [Abstract] [Full Text] [Related]